29 active trials 27 recruiting 18 disease areas 8 changes in 30 days
| Phase 1 | 24 | |
| Phase 1/2 | 3 | |
| Phase 2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05334823 | A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in… | Acute Lymphoblastic Leukemia | Recruiting | 2026-09-15 |
| Phase 1/2 | ||||
| NCT04271644 | BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell… | Multiple Myeloma | Recruiting | 2025-02-25 |
| NCT04776330 | a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory… | Multiple Myeloma | Recruiting | 2025-02-25 |
| NCT04781634 | a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory… | B-ALL | Recruiting | 2025-02-25 |
| Phase 1 | ||||
| NCT06690827 | Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/Refractory AML or BPDCN | AML (Acute Myeloid Leukemia) | Recruiting | 2026-08-28 |
| NCT07715630 | In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma | Relapsed or Refractory Multiple Myeloma (RRMM) | Recruiting | 2026-07-20 |
| NCT07456371 | PIC1 Injection Therapy for Relapsed/Refractory B-NHL | Non-Hodgkin Lymphoma | Recruiting | 2026-03-06 |
| NCT07403097 | Study of CD19 CAR-T Therapy for Refractory SLE | Systemic Lupus Erythematosus | Recruiting | 2026-02-11 |
| NCT07318259 | Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE | Systemic Lupus Erythematosus | Recruiting | 2026-02-03 |
| NCT07331467 | Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE | Systemic Lupus Erythematosus | Recruiting | 2026-01-12 |
| NCT06892145 | Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE | Systemic Lupus Erythematosus (SLE) | Recruiting | 2025-12-22 |
| NCT07239323 | In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies | B-Acute Lymphoblastic Leukemia | Recruiting | 2025-11-20 |
| NCT07179692 | CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors | Lung Cancer | Recruiting | 2025-10-02 |
| NCT07184450 | Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic… | Juvenile Dermatomyositis (JDM) | Recruiting | 2025-09-19 |
| NCT06945523 | Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the… | Advanced Lung Cancer | Recruiting | 2025-06-04 |
| NCT06992583 | Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer | Advanced Lung Cancer | Recruiting | 2025-05-28 |
| NCT06903117 | Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma | Advanced Lung Cancer | Recruiting | 2025-04-03 |
| NCT06909474 | Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic… | T-ALL/Lymphoma | Recruiting | 2025-04-03 |
| NCT06768151 | A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer | Advanced Lung Cancer | Recruiting | 2025-01-10 |
| NCT06686524 | Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes… | Dermatomyositis, Juvenile | Recruiting | 2024-11-13 |
| NCT06569472 | Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis | Juvenile Dermatomyositis | Recruiting | 2024-08-26 |
| NCT06215950 | A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive… | Ovarian Cancer | Recruiting | 2024-01-22 |
| NCT06180174 | Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma | B Cell Lymphoma | Recruiting | 2023-12-28 |
| NCT06126406 | Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA… | Gastric Cancer | Recruiting | 2023-11-13 |
| NCT06010862 | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic… | Gastric Cancer | Recruiting | 2023-11-08 |
Lung Cancer (8) · Acute Lymphoblastic Leukemia (ALL) (6) · Leukemia (5) · Colorectal Cancer (4) · Esophageal Cancer (4) · Gastric Cancer (4) · Lupus (SLE) (4) · Multiple Myeloma (4) · Pancreatic Cancer (4) · Breast Cancer (3)